Iovance Biotherapeutics Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
4
Price Target
$25.50
Consensus
Outperform
Upside
68.87%
Analysts
4
Stock Rating
4
Upside
68.87%
Analysts
4
Price Target
$25.50

Iovance Biotherapeutics Stock Forecast and Price Target

In recent months, four notable analysts have provided yearlong price targets for Iovance Biotherapeutics, with the average target coming in at $25.50. If it were to be achieved, this would result in a potential upside of approximately 68.87 percent from the most recent closing price in March, 2024. The high end is $34.00, and the low is $18.00. Even if you are not interested in IOVA stock, you should still be aware of its competitors.

$25.50

68.87% Upside

Buy
Buy

Iovance Biotherapeutics Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Iovance Biotherapeutics's Price has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Iovance Biotherapeutics, with analysts predicting Fair Value of $16.38 – an increase of 100.00%. Over the next seven years, experts anticipate that Iovance Biotherapeutics's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$16.38
2025 Fair Value Forecast
$18.22
2026 Fair Value Forecast
$20.26
2027 Fair Value Forecast
$22.52
2028 Fair Value Forecast
$25.04
2029 Fair Value Forecast
$27.85
2030 Fair Value Forecast
$30.96

Iovance Biotherapeutics Revenue Forecast for 2023 - 2025 - 2030

In the last zero years, Iovance Biotherapeutics's Revenue has decreased by 0.00%, from $1.19M to $1.19M. The next year looks promising for Iovance Biotherapeutics, with analysts predicting Revenue of $190.19M – an increase of 15882.35%. Over the next seven years, experts anticipate that Iovance Biotherapeutics's Revenue will grow at a rate of 134787.39%.

2024 Rev Forecast
$0.19B
2025 Rev Forecast
$0.54B
2026 Rev Forecast
$0.86B
2027 Rev Forecast
$1.19B
2028 Rev Forecast
$1.35B
2029 Rev Forecast
$1.50B
2030 Rev Forecast
$1.61B

Iovance Biotherapeutics Dividend per Share Forecast for 2023 - 2025 - 2030

Iovance Biotherapeutics Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$-296330000.00
2025 FCF Forecast
$0.09B
2026 FCF Forecast
$0.27B
2027 FCF Forecast
$0.35B
2028 FCF Forecast
$0.50B
2029 FCF Forecast
$0.61B
2030 FCF Forecast
$0.73B

Iovance Biotherapeutics EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Iovance Biotherapeutics's EBITDA has grown by 72.04%, rising from $-260.80M to $-448.68M. According to 2 major analysts, Iovance Biotherapeutics's EBITDA will fall by 16.81% in the next year, reaching $-373.25M. Professionals believe that By 2030, Iovance Biotherapeutics's EBITDA will fall to $-235.37M– a 47.54% decrease from its current value.

2024 EBITDA Forecast
$-373250000.00
2025 EBITDA Forecast
$-231890000.00
2026 EBITDA Forecast
$0.04B
2027 EBITDA Forecast
$-175000000.00
2028 EBITDA Forecast
$0.12B
2029 EBITDA Forecast
$-209201084.17
2030 EBITDA Forecast
$-235372139.80

Iovance Biotherapeutics EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Iovance Biotherapeutics's EBIT has grown by 75.83%, rising from $-261.94M to $-460.56M. In the next year, 11 analysts estimate that Iovance Biotherapeutics's EBIT will decrease by 24.60%, reaching $-347.24M. According to professional forecasts, in 2030, Iovance Biotherapeutics's EBIT will decrease by 211.38%, reaching $512.98M.

2024 EBIT Forecast
$-347240000.00
2025 EBIT Forecast
$-212230000.00
2026 EBIT Forecast
$0.13B
2027 EBIT Forecast
$0.35B
2028 EBIT Forecast
$0.38B
2029 EBIT Forecast
$0.46B
2030 EBIT Forecast
$0.51B

Iovance Biotherapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Iovance Biotherapeutics's EPS has grown, increasing from $-1.88 to $0.00 – a growth of 100.00%. The next year looks promising for Iovance Biotherapeutics, with analysts predicting EPS of $-1.44 – an increase of 100.00%. Over the next seven years, experts anticipate that Iovance Biotherapeutics's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-1.44
2025 EPS Forecast
$-1.13
2026 EPS Forecast
$-0.01
2027 EPS Forecast
$1.18
2028 EPS Forecast
$0.60
2029 EPS Forecast
$1.00
2030 EPS Forecast
$1.30